CLINICAL

Danish drugmaker Novo Nordisk said on Friday a phase 2 trial for its big hope in tackling obesity, an improved...

Medidata and Median Technologies announced a new collaboration to streamline the growth and use of medical imaging in cancer clinical trials....

DURECT Corporation announced that patient enrollment has been completed in PERSIST, the pivotal Phase 3 clinical trial of...

Enanta Pharmaceuticals, Inc., a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections...

Zydus announced the initiation of a phase II trial investigating ZYAN1, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI),...

Astellas Pharma Inc. and Pfizer Inc. announced the amendment of the protocol for the registrational PROSPER trial, a...

DRUG

Eisai Inc., the U.S. pharmaceutical subsidiary of Tokyo, Japan-based Eisai Co., Ltd., and Johns Hopkins University announced today...

New research conducted by scientists at the University of Sheffield into a drug candidate which could help to...

Mylan announced the U.S. launch of Rasagiline Tablets, 0.5 mg and 1 mg, a generic version of the reference...

Exscientia, an innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, is pleased to announce it...

Swedish Orphan Biovitrum has been granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for...

Numerate, Inc., a computational drug design company applying artificial intelligence (AI) at cloud scale to transform small molecule...

MANUFACTURING

US-based research-driven biotechnology company Integral Molecular has begun a therapeutic target discovery programme in immuno-oncology by utilising its...

Johnson & Johnson (J&J) has completed the acquisition of Actelion Pharmaceuticals for approximately $30bn in an all-cash transaction...

Exscientia, an innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, is pleased to announce it...

Virginia Cancer Specialists (VCS) opened a phase I clinical research facility in Fairfax, Northern Virginia, US, in June...

China's largest animal vaccine company Jinyu Bio-technology unveiled plans to establish its first US-based vaccine research lab and...

Tekni-Plex, Inc. is announcing a $15 million investment in a new state-of-the-art manufacturing facility in Suzhou, China, near...

PROJECTS & WHITEPAPERS

US-based biopharmaceutical company Pfizer began the construction of a new research and development (R&D) laboratory and office facility...

The presence of residual metal impurities during drug manufacturing has become a major issue in the pharmaceutical industry...

Systag Systems presents ePAT, a cost-effective device for automation in the laboratory. With its Plug & Play technology,...

Antibodies have generated a large amount of interest within the pharmaceutical industry, due in part to their ability...

Japan-based pharmaceutical company Takeda has initiated construction of a new high-containment production facility at its existing site in...

Charles Ischi showcases its tablet and testing technology in research and production: LAB.line, IPC.line, and accessories. LAB.line is...